Joel Peek

Joel Peek is currently the CEO, President, and Founder of Alimetrix. Joel was previously employed at the University of Alabama in Huntsville, Microarrays Inc, and Wyeth-Lederle. At Wyeth-Lederle, they worked as a senior scientist in vaccine development from January 1995 to December 2000. Prior to that, they were the operational manager at Chemlink- Atlantic Richfield from January 1984 to December 1987, where they worked as a polymer chemist/process design.

Joel Peek has a postdoctoral scholar at Stanford University School of Medicine in the field of host/pathogen interactions. Joel also has a Ph.D. in Molecular Biology-Bacterial Pathogenesis from The University of Tennessee Health Science Center. Lastly, they have a BS in Chemistry, Philosophy from the University of Tennessee.

Some individuals on their team include Mark McQuain - CTO, Jonas Boateng - Director of Next Generation Sequencing, and Carol Quinter - Laboratory Director of Clinical Services.